ES2098866T3 - Oligodesoxirribonucleotidos modificados, su preparacion y su utilizacion terapeutica. - Google Patents
Oligodesoxirribonucleotidos modificados, su preparacion y su utilizacion terapeutica.Info
- Publication number
- ES2098866T3 ES2098866T3 ES94300675T ES94300675T ES2098866T3 ES 2098866 T3 ES2098866 T3 ES 2098866T3 ES 94300675 T ES94300675 T ES 94300675T ES 94300675 T ES94300675 T ES 94300675T ES 2098866 T3 ES2098866 T3 ES 2098866T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- groups
- sulfur
- presented
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- -1 XANTHENYL Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical class CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/336—Modified G
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
SE PRESENTAN COMPUESTOS PARA EL TRATAMIENTO O PROFILAXIS DE UNA INFECCION VIRAL DE UN MAMIFERO, QUE PUEDE SER HUMANO. LOS COMPUESTOS SON DERIVADOS DEL ACIDO OLIGODESOXIRRIBONUCLEICO Y SE PRESENTA TAMBIEN UNA NUEVA MANERA PARA LA OBTENCION DE DICHOS COMPUESTOS ASI COMO LOS INTERMEDIOS QUE PRESENTAN UNA MAYOR UTILIDAD GENERAL. LOS COMPUESTOS ACTIVOS TIENEN LA FORMULA GENERAL (1): EN LA QUE R1, R2 Y R3 SON ATOMOS DE HIDROGENO, GRUPOS ALKILO, GRUPOS ARILO SEGUN QUEDAN DEFINIDOS Y GRUPOS ANTRAQUINONILO SEGUN QUEDAN DEFINIDOS; Z ES CARBONO O SILICIO; O R2, R3 Y Z REPRESENTAN JUNTOS FLUORENILO O XANTENILO; R4 ES UN ATOMO DE HIDROGENO, UN GRUPO ALKILO SEGUN QUEDA DEFINIDO, UN GRUPO ARILO SEGUN QUEDA DEFINIDO; Y1, Y3 E Y4 SON OXIGENO, AZUFRE O >NH; Y2 ES OXIGENO, AZUFRE, >NH, ALKILENO O FENILENO; X ES UN GRUPO ALKILENO SEGUN QUEDA DEFINIDO; M Y N SON DE 0 A 10; Y B ES UN OLIGODESOXIRRIBONUCLEOTIDO CON UNA LONGITUD DE CADENA DE 3 A 9; O LAS SALES DE LOS MISMOS.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1350993 | 1993-01-29 | ||
| JP13557393 | 1993-06-07 | ||
| JP13851793 | 1993-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2098866T3 true ES2098866T3 (es) | 1997-05-01 |
Family
ID=27280283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94300675T Expired - Lifetime ES2098866T3 (es) | 1993-01-29 | 1994-01-28 | Oligodesoxirribonucleotidos modificados, su preparacion y su utilizacion terapeutica. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5674856A (es) |
| EP (1) | EP0611075B1 (es) |
| KR (1) | KR100318796B1 (es) |
| CN (2) | CN1039014C (es) |
| AT (1) | ATE146479T1 (es) |
| AU (1) | AU670154B2 (es) |
| CA (1) | CA2114355A1 (es) |
| CZ (1) | CZ287050B6 (es) |
| DE (1) | DE69401136T2 (es) |
| DK (1) | DK0611075T3 (es) |
| ES (1) | ES2098866T3 (es) |
| FI (1) | FI111265B (es) |
| GR (1) | GR3022821T3 (es) |
| HK (1) | HK1000191A1 (es) |
| HU (1) | HU222834B1 (es) |
| IL (1) | IL108467A (es) |
| NO (1) | NO309427B1 (es) |
| NZ (2) | NZ280616A (es) |
| RU (1) | RU2111971C1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2114355A1 (en) * | 1993-01-29 | 1994-07-30 | Hidehiko Furukawa | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| US6291438B1 (en) | 1993-02-24 | 2001-09-18 | Jui H. Wang | Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use |
| CN1060177C (zh) * | 1997-06-28 | 2001-01-03 | 中国科学院上海生物化学研究所 | 3′－单磷酸化寡核苷酸 |
| GB9823646D0 (en) * | 1997-12-19 | 1998-12-23 | Brax Genomics Ltd | Compounds for mass spectrometry |
| US6995259B1 (en) | 1998-10-23 | 2006-02-07 | Sirna Therapeutics, Inc. | Method for the chemical synthesis of oligonucleotides |
| DE10041809A1 (de) * | 2000-08-25 | 2002-03-07 | Giesing Michael | Arrays immobilisierter Biomoleküle, deren Herstellung und Verwendung |
| US7205399B1 (en) | 2001-07-06 | 2007-04-17 | Sirna Therapeutics, Inc. | Methods and reagents for oligonucleotide synthesis |
| US9394167B2 (en) | 2005-04-15 | 2016-07-19 | Customarray, Inc. | Neutralization and containment of redox species produced by circumferential electrodes |
| US20070065877A1 (en) * | 2005-09-19 | 2007-03-22 | Combimatrix Corporation | Microarray having a base cleavable succinate linker |
| EP2511260B1 (en) * | 2009-12-08 | 2015-07-29 | Gifu University | Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct |
| WO2011090793A2 (en) | 2010-01-20 | 2011-07-28 | Customarray, Inc. | Multiplex microarray of serially deposited biomolecules on a microarray |
| CN102766183B (zh) * | 2011-05-05 | 2016-09-14 | 中国人民解放军军事医学科学院毒物药物研究所 | 具有抗hiv-1融合活性的修饰的核酸结构 |
| CN116496335B (zh) * | 2023-03-21 | 2024-03-08 | 中国药科大学 | 一种修饰核苷酸及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0035255B1 (en) * | 1980-02-29 | 1984-05-30 | University Patents, Inc. | Process for removing trityl blocking groups from 5'-o trityl nucleosides and oligonucleotides |
| US4849513A (en) * | 1983-12-20 | 1989-07-18 | California Institute Of Technology | Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups |
| FR2568254B1 (fr) * | 1984-07-25 | 1988-04-29 | Centre Nat Rech Scient | Application d'oligonucleotides lies a un agent intercalant, notamment a titre de medicament |
| US5252760A (en) * | 1985-03-28 | 1993-10-12 | Chiron Corporation | Method of using colored phosphorylating reagents |
| US4950745A (en) * | 1986-10-30 | 1990-08-21 | Daicel Chemical Industries, Ltd. | Process for synthesis of oligonucleotides and compound for forming polymeric protecting group |
| EP0290583B1 (fr) * | 1986-12-02 | 1993-04-07 | Centre National De La Recherche Scientifique (Cnrs) | OLIGONUCLEOTIDES $g(a) |
| US5276019A (en) * | 1987-03-25 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
| US4904582A (en) * | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
| WO1990012022A1 (en) * | 1989-03-31 | 1990-10-18 | University Patents, Inc. | Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections |
| CA2096658A1 (en) * | 1990-11-20 | 1992-05-21 | Hidehiko Furukawa | Anti-sense nucleic acid derivative |
| US5672697A (en) * | 1991-02-08 | 1997-09-30 | Gilead Sciences, Inc. | Nucleoside 5'-methylene phosphonates |
| US5220003A (en) * | 1991-03-29 | 1993-06-15 | The Regents Of The University Of California | Process for the synthesis of 2',3'-dideoxynucleosides |
| JP3061659B2 (ja) * | 1991-08-01 | 2000-07-10 | ヤマサ醤油株式会社 | ２−｛２−（モノメトキシトリチルオキシ）エチルチオ｝エチル基および該基の使用法 |
| IL104461A (en) * | 1992-01-22 | 2001-05-20 | Hoechst Ag | Oligonucleotide analogs, their preparation and pharmaceutical compositions containing them |
| US5646261A (en) * | 1992-01-22 | 1997-07-08 | Hoechst Aktiengesellschaft | 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use |
| CA2114355A1 (en) * | 1993-01-29 | 1994-07-30 | Hidehiko Furukawa | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| JPH09208729A (ja) * | 1996-02-02 | 1997-08-12 | Sekisui Chem Co Ltd | 帯電防止プラスチックプレートもしくはシートの製造方法 |
-
1994
- 1994-01-27 CA CA002114355A patent/CA2114355A1/en not_active Abandoned
- 1994-01-28 IL IL10846794A patent/IL108467A/en not_active IP Right Cessation
- 1994-01-28 ES ES94300675T patent/ES2098866T3/es not_active Expired - Lifetime
- 1994-01-28 RU RU94002329A patent/RU2111971C1/ru not_active IP Right Cessation
- 1994-01-28 DK DK94300675.9T patent/DK0611075T3/da active
- 1994-01-28 AU AU54731/94A patent/AU670154B2/en not_active Ceased
- 1994-01-28 FI FI940425A patent/FI111265B/fi active
- 1994-01-28 HU HU9400246A patent/HU222834B1/hu not_active IP Right Cessation
- 1994-01-28 CZ CZ1994190A patent/CZ287050B6/cs not_active IP Right Cessation
- 1994-01-28 AT AT94300675T patent/ATE146479T1/de not_active IP Right Cessation
- 1994-01-28 EP EP94300675A patent/EP0611075B1/en not_active Expired - Lifetime
- 1994-01-28 DE DE69401136T patent/DE69401136T2/de not_active Expired - Fee Related
- 1994-01-28 NO NO940310A patent/NO309427B1/no unknown
- 1994-01-29 CN CN94102610A patent/CN1039014C/zh not_active Expired - Fee Related
- 1994-01-29 KR KR1019940001828A patent/KR100318796B1/ko not_active Expired - Fee Related
- 1994-01-31 NZ NZ280616A patent/NZ280616A/xx unknown
- 1994-01-31 NZ NZ250795A patent/NZ250795A/xx unknown
-
1995
- 1995-02-23 US US08/393,510 patent/US5674856A/en not_active Expired - Fee Related
- 1995-06-01 US US08/457,151 patent/US5807837A/en not_active Expired - Fee Related
-
1997
- 1997-03-17 GR GR970400495T patent/GR3022821T3/el unknown
- 1997-08-09 CN CN97117470A patent/CN1065238C/zh not_active Expired - Fee Related
- 1997-09-02 HK HK97101710A patent/HK1000191A1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2098866T3 (es) | Oligodesoxirribonucleotidos modificados, su preparacion y su utilizacion terapeutica. | |
| ES2133163T3 (es) | Esteres (o tioesteres) del acido n-acilsulfamico y esteres (o tioesteres) del acido n-sulfonilcarbamico como agentes hipercolesterolemicos. | |
| ES2112332T3 (es) | Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico. | |
| ATE282614T1 (de) | Phenylharnstoff und phenylthioharnstoffderivate | |
| DE69918404D1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| EA200300792A1 (ru) | Хиназолины в качестве ингибиторов ммр-13 | |
| EA200200708A1 (ru) | Производные бензазола и их применение в качестве модуляторов jnk | |
| ES2111654T3 (es) | Derivados de piperazina como antagonistas de 5-ht1a. | |
| ATE234099T1 (de) | Immununterdrückende effekte von 8 substituierten xanthinderivaten | |
| FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
| DK1295871T3 (da) | Vitamin D-derivater med et 22-oxa- eller 22-thiaatom, en C17-sidekæde substitueret med en syre-, ester- eller amid-gruppe og en 16(17)-dobbeltbinding | |
| ES2110260T3 (es) | Androstenonas. | |
| ES2176719T3 (es) | Derivados de benzopirano que tienen una accion antagonista de leucotrienos. | |
| CO4980887A1 (es) | Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico | |
| ES2052504T3 (es) | Derivado de difenilmetano, compuesto farmaceutico y su utilizacion. | |
| ES2058203T3 (es) | Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos. | |
| ES2062407T3 (es) | Compuestos de 2-hidroxi-3-fenoxipropilamino. | |
| ATE271542T1 (de) | 2-thiocarbamoyloxy- und 2-carbamoyloxy-derivate von cyclopentyl-heptan(en)säure als therapeutische mittel | |
| EA199800176A1 (ru) | Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов | |
| EA199900460A1 (ru) | Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные | |
| KR910021407A (ko) | 바이러스에 의해 유발된 질환을 치료하기 위한 벤질포스폰산 유도체의 용도 | |
| DK1120415T3 (da) | Substituerede isoxazolylthiophenforbindelser | |
| BG106846A (en) | Novel heteroaryl derivatives, their preparation and use | |
| ES2043778T3 (es) | Procedimiento para preparar oxiindanos y tetrahidronaftalenos herbicidas. | |
| FR2665362B1 (fr) | Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 611075 Country of ref document: ES |